Skip to main content
Caplight Logo









Baymatob

Baymatob

Private
LeichhardtHealthcare & Life Scienceshttps://baymatob.com/

Last Round

Series A

Extension

May 26, 2026

Total Funding Raised

$14.48M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Baymatob is a medical device company developing an AI-powered maternal-fetal health platform designed to provide early warning for serious complications in pregnancy and labor.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical AI, Health IoT

Business Model

B2B

Customer Profile

Hardware + Subscription, Government Contracts

AI Layer

Application

Keywords

postpartum hemorrhagePPH predictionmaternal monitoringwearable medical deviceFemTechpredictive diagnosticsAI medical deviceMedTechwearable sensorfetal monitoringlabor and delivery monitoringclinical decision supportobstetrics technologyFDA breakthrough device

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Baymatob Comparables

Compare Baymatob with similar companies based on industry and business-model similarity.

Baymatob comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Vasowatch
82%
VitalTrace
81%
Biorithm
79%

Baymatob Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series A ExtensionMay 26, 2026
GrantMay 5, 2026
GrantDec 23, 2024
Series A ExtensionMar 1, 2024
Series AMar 21, 2022
Grant
Aug 21, 2019

Baymatob Investors

Notable investors and investment history

Baymatob investors
InvestorRounds
Even CapitalSeries A Extension, Series A
Scale InvestorsSeries A Extension, Series A
NSW Medical Device FundGrant
ANDHealthGrant
Clare VenturesSeries A Extension

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 26, 2026

    $7M round with participation from Clare Ventures and Scale Investors.

  • May 17, 2026

    Monthly visitors grew 267% MoM, from 464 to 1.7K.

Baymatob Filings

Explore SEC and related filing metadata, where available.

Baymatob filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Baymatob's valuation, stock price, and market status.

Is Baymatob a public or private company?

Baymatob is a private company.

What is the current stock price of Baymatob?

Baymatob is a private company with no public stock price. No recent secondary market data is available.

How much is Baymatob worth (valuation)?

Valuation information for Baymatob is not publicly available.

Can I buy Baymatob stock?

Baymatob shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Baymatob's last funding round?

Funding round information for Baymatob is not publicly available.

Who are the main investors in Baymatob?

Investor information for Baymatob is not publicly disclosed.

Will Baymatob IPO soon?

No public IPO plans have been announced for Baymatob.

How can I track Baymatob secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Baymatob's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersLeichhardt
Employee Range20
Year Founded2013
Last FundingMay 26, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?